ReviewOpen medicine (Warsaw, Poland)2022

The rationale for using low-molecular weight heparin in the therapy of symptomatic COVID-19 patients.

Edyta Reichman-Warmusz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.